At Penn Medicine, patients with small intestine cancer receive their care from a multidisciplinary team of nationally recognized experts in the diagnosis, treatment and research of gastrointestinal cancer.
Also known as the small bowel, the small intestine is the portion of the digestive tract that connects the stomach with the large bowl, or colon. The small intestine is critical in the breakdown and absorption of food so the body can absorb nutrients.
The small intestine can be divided into three areas:
Cancer of the small intestine is rare. There are five main types of intestinal cancer, differentiated by their appearance under a microscope:
Penn Medicine's multidisciplinary approach to cancer diagnosis and treatment provides better outcomes and gives patients access to the most advanced treatment, surgical techniques and clinical trials.
Because navigating a cancer diagnosis and treatment options can be difficult, patients who wish to connect with a cancer specialist at Penn Medicine can speak with a cancer nurse, who can help them make an appointment with the right physician.
To connect with a cancer nurse at Penn Medicine, patients should call 800-789-PENN.
Some risk factors for cancer, like age and family history, cannot be prevented. Patients who feel they are at risk may benefit from consulting with a risk assessment specialist within one of Penn Medicine’s programs at the Abramson Cancer Center or the Joan Karnell Cancer Center at Pennsylvania Hospital.
There are different kinds of risk factors for small intestine cancer.
Most risk factors for intestinal cancer cannot be prevented. However, there are preventive measures people can take to decrease the risk of developing cancer.
Penn Medicine offers programs for patients who want to determine their risk of developing gastrointestinal cancer through:
These programs offer knowledge about the presence of genetic risk factors for cancer and provide patients with important, sometimes life-saving options.
The most common type of intestinal cancer, adenocarcinoma, begins in the lining of the small intestine and usually develops in the duodenum.
Also known as neuroendocrine tumors, these tumors are slow growing and usually occur in the ileum.
Lymphoma is cancer that starts in the lymph tissue of the small bowel and usually occurs in the jejunum. Lymphomas are typically non-Hodgkin’s lymphoma, but they can also be Hodgkin’s lymphomas. Occasionally, T-cell lymphomas can develop with long-standing celiac disease.
Sarcomas in the small intestine begin in the muscle wall and usually occur in the ileum.
The most common subtype of sarcoma in the small intestine.
Because intestinal cancer is so rare, it can be difficult to diagnose. Its symptoms are usually nonspecific:
While these symptoms could be caused by a number of medical conditions, if symptoms such as these are severe, worsening, or persistent, medical attention should be sought so that a timely and accurate diagnosis can be made. Anytime blood is seen in the stool or the stool is black, medical attention should be sought.
Staging systems provide doctors with a common language for describing tumors. After cancer is first diagnosed, a series of tests are used to investigate the extent of the cancer and to see whether it has spread to other parts of the body from where it started. Staging is a way of recording the size and growth of a cancer, and determining the plan for treatment. By understanding the stage of their cancer, patients can make informed decisions about treatment.
The “staging diagnosis” depends on the type of cancer and the staging system the doctor is using, but in general there are four stages of intestinal cancer:
After being diagnosed with small intestine cancer, patients at the Abramson Cancer Center may be evaluated through the Gastrointestinal Cancer Evaluation Center (GICEC). The center provides patients with expert support and evaluation to discuss treatment options and individualized treatment plans.

Patients with small intestine cancer are treated by a multidisciplinary team of cancer specialists who see more patients with gastrointestinal (GI) cancers in one year than many doctors see in their careers.
The physicians of Penn Medicine's GI cancer program are nationally recognized for their expertise in the diagnosis and treatment of cancer.
Penn’s GI cancer treatment team includes:
Penn’s GI cancer program is also supported by a robust research program with immediate translation from bench to bedside.
Many treatment options including standard treatments and clinical trials are available for those with small intestine cancer.
A clinical trial is a study meant to help improve current treatments or obtain information about new treatments. Patients at Penn Medicine can benefit from participating in clinical trials that take place at Penn. Patients interested in learning more about clinical trials should speak with someone on their treatment team.
Every step of cancer treatment; from a cancer diagnosis, to surgery and treatment to forming a survivorship plan; comes with different needs and issues that should be addressed.
Oncology Navigation Specialists at the Abramson Cancer Center are available to make a patient’s experience as seamless as possible. As experts in navigating complex health care situations, patient support specialists serve as a consistent point of contact and a reliable source for advice, support and direction for patients and families. They can help in a variety of ways including; provide emotional support, identify resources, and ensure access to information, support services, educational programs and community resources.
Learn more about Patient Navigation specialists at the Abramson Cancer Center.
An accurate cancer diagnosis from trusted cancer specialists is the first step in getting personalized treatment options to treat small intestine cancer.
Patients who choose Penn’s Abramson Cancer Center, benefit from a multidisciplinary team of cancer specialists including gastroenterologists, radiologists, pathologists and surgeons who work together to provide a diagnosis and treatment plan custom designed for each patient with small intestine cancer.
Cancer specialists at Penn Medicine are highly experienced in using the most advanced techniques for diagnosing small intestine cancer and are actively researching better and more precise ways to detect small intestine cancer.
Because an accurate diagnosis is a critical step in planning cancer treatment, it’s important patients know that when they come to Penn Medicine’s Abramson Cancer Center, they are taking an important step in getting the best cancer treatment.
Navigating a cancer diagnosis and treatment options can be difficult, patients who wish to connect with a cancer specialist at Penn Medicine can speak with a cancer nurse, who can help them make an appointment with the right person. Penn Medicine’s contact center has experienced cancer nurses available and ready to guide patients in finding the cancer specialist right for them.
To connect with a cancer nurse at Penn Medicine, patients should call 800-789-PENN.
Currently, there are no standard intestinal cancer screening recommendations for the general public like there mammograms for breast cancer and colonoscopy for colon cancer.
When physicians suspect intestinal cancer, they may order several tests to make a diagnosis.
Staging systems provide doctors with a common language for describing tumors. After cancer is first diagnosed, a series of tests are used to investigate the extent of the cancer and to see whether it has spread to other parts of the body from where it started. Staging is a way of recording the size and growth of a cancer, and determining the plan for treatment. By understanding the stage of their cancer, patients can make informed decisions about treatment.
The “staging diagnosis” depends on the type of cancer and the staging system the doctor is using, but in general there are four stages of intestinal cancer:
Physicians also group small intestine cancer based on whether or not it can be surgically removed, or resected. If the cancer can be surgically removed, the prognosis and outcome for a patient is improved.
Following the diagnosis and staging of small intestine cancer, cancer specialists at Penn’s Abramson Cancer Center develop a personalized treatment plan. Penn’s treatment options for small intestine cancer include:
Because navigating a cancer diagnosis and treatment options can be difficult, patients who wish to connect with a cancer specialist at Penn Medicine can speak with a cancer nurse, who can help them make an appointment with the right physician.
To connect with a cancer nurse at Penn Medicine, patients should call 800-789-PENN.
Surgery is the most common treatment for intestinal cancer.
When the tumor is resectable, radical surgery offers the best chance for cure.
Resection is surgery that removes all or part of an organ that contains cancer. Resection surgery may include the small intestine and nearby organs if the cancer has spread. Surgeons may remove the section of the small intestine that contains the cancer and join the cut ends of the small intestine together. This procedure is called an anastomosis. Surgeons may also remove affected lymph nodes during the procedure.
When the tumor cannot be completely resected, a surgical bypass can relieve symptoms. This procedure reroutes the small intestine, allowing food to go around a tumor that cannot be removed.
Radiation oncologists at Penn Medicine are recognized for techniques that target radiation precisely to the disease site while sparing nearby tissue.
Proton therapy at Penn Medicine is now being used to treat upper gastrointestinal cancers and recurrent tumors in the digestive tract. Penn Medicine is one of the only facilities in the country treating gastrointestinal cancers in this way.
Radiation therapy uses high-energy radiation to kill cancer cells. A radiation therapy schedule usually consists of a specific number of treatments given over an extended period of time. In many cases, radiation therapy is capable of killing all of the cancer cells.
The imaging technology used by radiation oncologists at Penn Medicine helps shape the radiation treatment beam to the shape of the tumor. Known as conformal radiation therapy, this technology gives doctors more control when treating tumors.
In conformal radiation, a special computer uses CT imaging scans to create 3-D maps of the location of the cancer in the body. The system permits the delivery of radiation from several directions, and the beams can then be shaped, or conformed, to match the shape of the cancer. Conformal radiation therapy limits radiation exposure to nearby healthy tissue as well as the tissue in the beam's path.
As national leaders in radiation therapy, radiation oncologists at Penn Medicine are experts in the use of the latest therapies, including intensity-modulated radiation therapy (IMRT), to treat cancer.
This advanced type of radiotherapy uses a computer-controlled device, called a linear accelerator, to deliver precise doses of radiation to tumors or specific areas within the tumors. Radiation therapy, including IMRT, stops cancer cells from dividing and growing, thus killing the cancer cells and preventing tumor growth.
In many cases, radiation therapy is capable of killing all of the cancer cells. Using 3-D computed tomography (CT) images of the patient along with computerized dose calculations, IMRT allows for the radiation dose to conform more precisely to the three-dimensional shape of the tumor by controlling; or modulating; the intensity of the radiation beam. The therapy allows higher radiation doses to be delivered to regions within the tumor while minimizing the dose to the surrounding area.
Penn Medicine is the only academic medical center in the country that is using proton therapy to treat recurrent gastrointestinal tumors in clinical trials. Also, radiation oncologists at Penn Medicine will soon use proton therapy to treat gastrointestinal cancers in the upper digestive tract.
Penn Medicine's Roberts Proton Therapy Center is the largest and most advanced facility in the world for this precise form of cancer radiation. Patients have access to one of the most sophisticated weapons against cancer, seamlessly integrated with the full range of oncology services available at Penn Medicine. Proton therapy is external beam radiotherapy in which protons are directed at a tumor.
The radiation dose that is given through protons is very precise, and limits the exposure of normal tissues. This allows the radiation dose delivered to the tumor to be increased beyond conventional radiation. The result is a better chance for curing cancer with fewer harmful side effects.
Proton therapy, like all forms of radiation therapy, works by aiming the energized particles, in this case protons, onto the target tumor. The particles damage the DNA of cells, ultimately causing their death. Unlike X-rays, protons can be manipulated to release most of their energy only when they reach their target. With more energy reaching the cancerous cells, more damage is administered by each burst of radiation.
Volumetric-modulated arc therapy (VMAT) is a type of specialized intensity modulated radiation therapy, or IMRT. VMAT delivers radiation by rotating the radiation machine, through one or more arcs while radiation is continuously delivered.
VMAT allows Penn radiation oncologists to treat complex cancers while minimizing exposure to surrounding healthy tissue. VMAT shortens radiation delivery time, and offers patient more comfort because it does not require patients to lie completely still for long periods of time.
Penn radiation oncologists use RapidArc™ radiotherapy technology to treat hard to reach tumors.
Penn Medicine specializes in a team approach to treatment with interdisciplinary care and innovative approaches that use chemotherapy to target tumors prior to surgery.
Chemotherapy uses drugs to kill cancer cells. It is delivered through an intravenous catheter or a pill and targets cancer cells throughout the body. Depending on the stage of the tumor, chemotherapy may be given after surgery or in combination with radiation therapy.
Today, more and more people are surviving cancer. Clinical trials, many of which are conducted at Penn Medicine benefit patients through breakthrough therapies and treatments. These new advances in cancer treatment are occurring every day, giving patients hope that even greater discoveries lie ahead. Through clinical trials:
Biologic therapy, also called targeted therapy, uses the patients' own immune system to target cancer cells. Substances made by the body or in a laboratory are used to boost, direct or restore the body's natural defenses against cancer, and are delivered orally by pill or intravenously. This type of cancer treatment is also called immunotherapy.
Radiation therapy with radiosensitizers is currently being studied in clinical trials. Radiosensitizers are drugs that make tumor cells more sensitive to radiation therapy. Combining radiation therapy with radiosensitizers may kill more tumor cells.
If the tumor is blocking the duodenum, a stent may be placed to bypass the blockage.
In addition to standard treatments and clinical trials, patients at Penn Medicine may wish to add additional therapies and treatments such as massage therapy, acupuncture and art therapy. These therapies do not have curative intent, and are designed to complement standard treatments, not take their place.
At Penn Medicine, integrative medicine and wellness services can supplement traditional cancer treatments such as chemotherapy, surgery and radiation therapy. While conventional medicine plays a critical role in eradicating cancer, integrative medicine and wellness programs offer patients and their families ways to enhance the quality of their lives, minimize or reduce the side effects of cancer and cancer treatment, and promote healing and recovery.
Cancer specialists at Penn Medicine are knowledgeable and supportive of complementary cancer treatments. The cancer team works with patients and families to integrate these supportive programs into the overall care plan, while ensuring the safety and health of patients.
The Abramson Cancer Center’s range of integrative supportive services is designed to help patients cope with the cancer experience and improve their overall sense of well-being. Services include:
The Joan Karnell Cancer Center at Pennsylvania Hospital offers a variety of supportive care programs for patients and families, from diagnosis through survivorship. These programs are available at no cost to the patients treated at Pennsylvania Hospital, and some are open to patients treated elsewhere. These services include social work counseling, nutrition counseling, psychological counseling and spiritual counseling.
The Cancer Appetite and Rehabilitation Clinic focuses on patients with loss of appetite and weight.
The Supportive Care Clinic helps to manage cancer related symptoms. Integrative support programs include:
Support groups and educational programs are available at Pennsylvania Hospital throughout the year.
Palliative care provides medical and non-medical interventions to ease the symptoms of cancer and its treatment. Palliative care includes physical, emotional and spiritual care that can enhance the quality of life for cancer patients.
Palliative care can be used to complement traditional cancer therapies, or to and improve quality of life when curative therapies are no longer an option.
Palliative care is an approach to patient care that can be integrated with curative therapies at any point from diagnosis to survivorship or end-of-life care.
Palliative care services include palliative chemotherapy, radiation therapy and surgery as well as psychological counseling, art therapy and support groups for patients and families. The goals of palliative care are to enhance the quality of life for cancer patients and their families, and provide emotional and spiritual support to enhance personal growth.
Palliative care services are offered at Pennsylvania Hospital, and at the Hospital of the University of Pennsylvania.
Penn Home Care and Hospice Services offer a full range of home health care needs by partnering three top-level home health care services under one roof:
Penn Home Care and Hospice Services offer an array of specialized therapies and medications for patients with cancer and cancer-related conditions.
Every step of cancer treatment; from a cancer diagnosis, to surgery and treatment to forming a survivorship plan; comes with different needs and issues that should be addressed.
Oncology Navigation Specialists at the Abramson Cancer Center are available to make a patient’s experience as seamless as possible. As experts in navigating complex health care situations, patient support specialists serve as a consistent point of contact and a reliable source for advice, support and direction for patients and families. They can help in a variety of ways including; provide emotional support, identify resources, and ensure access to information, support services, educational programs and community resources.
Learn more about Patient Navigation specialists at the Abramson Cancer Center.
Survivorship programs at Penn Medicine are a distinct phase of intestinal cancer care and are designed to help patients' transition from their cancer treatment routine to a post-cancer care lifestyle. There are more than 12 million cancer survivors living and thriving today as a result of advances in cancer treatment. However, cancer treatments can result in physical, emotional and financial complications long after the therapy is complete.
At the end of treatment, cancer patients should schedule a survivorship visit with their oncologist and nurse practitioner. At this time, patients are provided with a summary of the treatment received as well as a plan for follow-up care.
Long-term intestinal cancer survivors should speak to their oncologist and nurse practitioner about scheduling a one-time survivorship-focused consultation with a nurse practitioner or physician. Annual or more frequent follow-up appointments are also available.
Penn cancer providers work one-on-one with patients to develop survivorship care plans. Since every cancer is unique, the plans are tailored to the patients.
The survivorship care plan includes information on:
A survivorship care plan encourages patients to review the information with their health care team and become active participants in their follow-up care.
Penn also offers small intestine cancer patients a number of support programs and groups to enhance their survivorship care plans.
Every step of cancer treatment; from a cancer diagnosis, to surgery and treatment to forming a survivorship plan; comes with different needs and issues that should be addressed.
Oncology Navigation Specialists at the Abramson Cancer Center are available to make a patient’s experience as seamless as possible. As experts in navigating complex health care situations, patient support specialists serve as a consistent point of contact and a reliable source for advice, support and direction for patients and families. They can help in a variety of ways including; provide emotional support, identify resources, and ensure access to information, support services, educational programs and community resources.
Learn more about patient navigation specialists at the Abramson Cancer Center.
Penn Medicine’s Living Well After Cancer™ Program is a nationally recognized program that focuses on issues facing cancer survivors. In 2007, the Abramson Cancer Center was designated a LIVESTRONG™ Survivorship Center of Excellence Network. The Abramson Cancer Center is only one of eight LIVESTRONG centers in the United States, and is the only LIVESTRONG Survivorship Center of Excellence in the Philadelphia region. The program focuses on survivorship, a distinct phase of care.
Prescription for Living: The Cancer Survivorship Program at the Joan Karnell Cancer Center at Pennsylvania Hospital, provides patients with a summary of important information about specific cancer diagnoses and treatments, as well as follow-up information and steps to take towards recovery, supportive care and education to help patients adjust to their lives as cancer survivors.
Penn Medicine offers cancer patients support programs and groups to enhance their survivorship care plans.
The Abramson Cancer Center and Joan Karnell Cancer Center at Pennsylvania Hospital provide materials and host a wide range of activities that provide education and support to address key areas of concern including survivorship for cancer patients and their loved ones.
Focus On: Gastrointestinal Cancers is a day-long conference for patients and their loved ones that addresses issues surrounding gastrointestinal cancers.
Edith Christmas lives up to the giving spirit of her last name. While caring for her ailing sister, Edith ignored the pain she was experiencing.
Watch CANPrevent Colorectal Cancer Conference to learn about your risk for developing colorectal cancer.
Watch Focus on Gastrointestinal Cancers Conference - Get information on the latest advances in gastrointestinal cancer risk, prevention, diagnosis, treatment, symptom management and psychosocial issues.
Watch Focus On Pancreatic Cancer Conference - Get information on the latest advances in pancreatic cancer risk, prevention, diagnosis, treatment, symptom management and psychosocial issues.
Watch the Focus On Neuroendocrine Tumors Conference
NBC10 Colorectal Cancer Awareness Month
Video with Dr. Gregory Ginsberg
OncoLink's" The Basics" -- Learn basic information about different gastrointestinal cancers.
OncoLink - Advances in Colorectal Cancer Screening. Read OncoLink's brown bag chat transcript.
Clinical Briefing: Management of Neuroendocrine Tumors
Abramson Cancer Centers Gastrointestinal Cancer Program is conducting exciting, innovation research entitled "The Mechanisms of Esophageal Carcinogenesis." This important project will define underlying mechanisms in the development of esophageal cancer that will lead to new ways to diagnose and treat this cancer. Find out more...